Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 17 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $550 100.0% | $436 100.0% | $672 100.0% | $46K 100.0% | $4K 100.0% | — |
| Research & Development | — | $167K 38226.4% | $1.4M 201103.4% | $515K 1114.3% | — | — |
| Selling, General & Admin | $730K 132762.0% | $590K 135297.0% | $893K 132882.7% | $992K 2146.3% | $608K 13669.8% | $106K |
| Total Operating Expenses | $5.5M 998292.4% | $3.2M 737982.3% | $8.8M 1307247.5% | $12.3M 26556.8% | — | — |
| Operating Income | -$5.5M -998192.4% | -$3.2M -737882.3% | -$8.8M -1307147.5% | -$12.2M -26456.8% | -$10.8M -243836.9% | — |
| Interest Expense | $752 136.7% | — | — | — | $127 2.9% | $45K |
| Interest & Investment Income | $173K 31409.8% | $269K 61640.4% | $384K 57157.4% | $12K 26.6% | $4K 79.1% | $107 |
| Other Income (Expense), net | $235K 42802.2% | $269K 61640.4% | $379K 56407.9% | $88K 190.7% | $10K 214.1% | $105K |
| Net Income | -$2.6M -474049.5% | -$4.2M -972284.4% | -$8.4M -1250739.6% | -$12.1M -26266.0% | -$10.8M -243622.8% | -$979K |
| Per Share | ||||||
| EPS (Basic) | $-0.62 | $-1.43 | $-4.14 | $-6.04 | $-0.71 | — |
| EPS (Diluted) | $-0.62 | $-1.43 | $-4.14 | $-6.04 | $-0.71 | — |
| Weighted Avg Shares (Basic) | 4.2M | 3.0M | 2.0M | 2.0M | 15.3M | — |
| Weighted Avg Shares (Diluted) | 4.2M | 3.0M | 2.0M | 2.0M | 15.3M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
1/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$4M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 6 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -43%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 6 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
No current price collected.
No standout strengths flagged.
Where each multiple sits in its own 5-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D | — | — | 1114.3 | 201103.4 | 38226.4 | — |
| SG&A | — | 13669.8 | 2146.3 | 132882.7 | 135297.0 | 132762.0 |
| Operating Income | — | -243836.9 | -26456.8 | -1307147.5 | -737882.3 | -998192.4 |
| Net Income | — | -243622.8 | -26266.0 | -1250739.6 | -972284.4 | -474049.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MYSE: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.